Last reviewed · How we verify

NCT03661255: PC CARES

Promoting Community Conversations About Research to End Native Youth Suicide in Rural Alaska

Active, enrolled NA Last updated 19 February 2025
What this trial tests

NA trial testing PC CARES in Suicide in 1,491 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
12 September 2019
Primary endpoint
18 February 2025
15 December 2025

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment1,491
Start date12 September 2019
Primary completion18 February 2025
Estimated completion15 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

15 and older, any sex, with Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This intervention study measures the outcomes of the PC CARES (Promoting Community Conversations about Research to End Suicide) project implemented in remote rural Alaskan villages. Researchers worked with local service providers and other partners to recruit facilitators who were trained to implement the 5-session PC CARES curriculum. The study will compare pre-post data from intervention participants to non-participants, and will analyze social networks related to suicide prevention behavior in each village.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03661255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing